BFEC
NVRO

Benjamin F. Edwards & Company’s NEVRO CORP. NVRO Stock Holding History

Benjamin F. Edwards & Company’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$3K Buy
300
+188
+168% +$2K ﹤0.01% 2009
2024
Q1 		$2K Buy
+112
New +$1.85K ﹤0.01% 2055

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Benjamin F. Edwards & Company's NVRO Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its NEVRO CORP. (NVRO) stake by 168% in Q2 2024, buying an estimated $2K and bringing the position to 300 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #2009.

Benjamin F. Edwards & Company first reported a position in NVRO in Q1 2024 and has held it in 2 quarters since. 152 funds tracked by Wall St. Rank hold NVRO as of Q2 2024.

  • Benjamin F. Edwards & Company held 300 shares of NEVRO CORP. worth $3K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 188 NEVRO CORP. shares in Q2 2024, an estimated $2K.
  • NEVRO CORP. made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #2009 holding.
  • Benjamin F. Edwards & Company first reported a position in NEVRO CORP. in Q1 2024 and has held it in 2 quarters since.
  • 152 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.